{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:40:18Z","timestamp":1785393618069,"version":"3.55.0"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T00:00:00Z","timestamp":1600560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["IIR 16\u2010210"],"award-info":[{"award-number":["IIR 16\u2010210"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA045705"],"award-info":[{"award-number":["R01DA045705"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["agsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND\/OBJECTIVES<\/jats:title>\n                    <jats:p>Benzodiazepines (BZDs) are widely prescribed to older adults. Although prescribing has declined in the U.S. Department of Veterans Affairs (VA), Medicare introduced BZD coverage in 2013. It is unknown whether declines in the VA have been widespread among older adults in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN<\/jats:title>\n                    <jats:p>Observational study in traditional fee\u2010for\u2010service Medicare, commercial insurance, and the VA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING<\/jats:title>\n                    <jats:p>United States, 2013\u20132017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS<\/jats:title>\n                    <jats:p>Adults aged 55 and older in traditional Medicare (234,290,693 person\u2010months), commercial insurance (337,827,125 person\u2010months), and the VA (256,590,369 person\u2010months).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS<\/jats:title>\n                    <jats:p>(1) Change in BZD and BZD\u2010opioid co\u2010prescribing modeled by Poisson regression over time; and (2) standardized ratios of BZD and BZD\u2010opioid co\u2010prescribing, using Medicare as the reference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      From April 2013 to December 2017, the monthly percentage of adults aged 55 and older who received BZDs fell from 10.4% to 9.3% in Medicare, 6.6% to 6.5% in commercial insurance, and 5.7% to 3.0% in the VA. Monthly BZD\u2010opioid co\u2010prescribing over the same time fell from 4.0% to 3.0% in Medicare, 2.3% to 2.0% in commercial, and 2.2% to .6% for the VA. Age\u2010 and sex\u2010adjusted rates of decline for BZD and BZD\u2010opioid co\u2010prescribing were statistically significant for all systems. Annual BZD rate reductions were .98 (Medicare), .99 (commercial), and .87 (VA;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;\u2009.001 for all); co\u2010prescribing rate reductions were .95, .99, and .75 (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;\u2009.001 for all). Using standardized ratios accounting for demographic and clinical characteristics, both prescribing and co\u2010prescribing were lowest for the VA relative to Medicare (standardized BZD ratio = .40; 95% confidence interval [CI] = .39\u2013.40; standardized BZD\u2010opioid co\u2010prescribing ratio = .35; 95% CI =\u2009.35\u2013.35). Prescribing in commercial insurance was also lower (BZD = .65; 95% CI =\u2009.65\u2013.65; BZD\u2010opioid co\u2010prescribing = .65; 95% CI =\u2009.65\u2013.65).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>BZD prescribing has declined much more to older adults receiving care through the VA than Medicare or commercial insurance. Other systems may learn from strategies implemented in the VA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jgs.16825","type":"journal-article","created":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T08:02:45Z","timestamp":1600588965000},"page":"98-105","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Benzodiazepine Use among Medicare,\n                    <scp>Commercially Insured<\/scp>\n                    , and Veteran Older Adults, 2013\u20132017"],"prefix":"10.1111","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-2640","authenticated-orcid":false,"given":"Donovan T.","family":"Maust","sequence":"first","affiliation":[{"name":"Department of Psychiatry University of Michigan  Ann Arbor Michigan"},{"name":"Center for Clinical Management Research VA Ann Arbor Healthcare System  Ann Arbor Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan  Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Myra","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Clinical Management Research VA Ann Arbor Healthcare System  Ann Arbor Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan  Ann Arbor Michigan"},{"name":"Center for Statistical Consultation and Research University of Michigan  Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse R.","family":"Wiechers","sequence":"additional","affiliation":[{"name":"Northeast Program Evaluation Center, Office of Mental Health and Suicide Prevention Department of Veterans Affairs  West Haven Connecticut"},{"name":"Department of Psychiatry University of California, San Francisco  San Francisco California"},{"name":"Department of Psychiatry Yale University School of Medicine  New Haven Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda V.","family":"Ignacio","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Michigan  Ann Arbor Michigan"},{"name":"Center for Clinical Management Research VA Ann Arbor Healthcare System  Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.B.","family":"Bohnert","sequence":"additional","affiliation":[{"name":"Center for Clinical Management Research VA Ann Arbor Healthcare System  Ann Arbor Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan  Ann Arbor Michigan"},{"name":"Department of Anesthesiology University of Michigan  Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic C.","family":"Blow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry University of Michigan  Ann Arbor Michigan"},{"name":"Center for Clinical Management Research VA Ann Arbor Healthcare System  Ann Arbor Michigan"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan  Ann Arbor Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812293192604"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03430230088031"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400090107019"},{"key":"e_1_2_6_5_1","unstructured":"American Geriatrics Society. Ten things physicians and patients should question. Choosing Wisely. ABIM Foundation 2015.http:\/\/www.choosingwisely.org\/societies\/american-geriatrics-society\/. Accessed August 2 2017."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04325"},{"issue":"8","key":"e_1_2_6_7_1","first-page":"639","article-title":"A systematic review of amnestic and non\u2010amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs","volume":"29","author":"Tannenbaum C","year":"2012","journal-title":"Drugs Aging"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j760"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.272"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2698"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303061"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-006-0021-3"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0205-5"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02364.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2005.00674.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.949"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.189.3.213"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15292"},{"key":"e_1_2_6_19_1","unstructured":"Centers for Medicare & Medicaid Services. Transition to Part D coverage of benzodiazepines and barbiturates beginning in 2013.https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/BenzoandBarbituratesin2013.pdf. Accessed May 6 2016."},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800321"},{"key":"e_1_2_6_21_1","unstructured":"Congressional Research Service. The number of veterans that use VA health care services: a fact sheet.https:\/\/fas.org\/sgp\/crs\/misc\/R43579.pdf. Accessed March 30 2020."},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2017.08.042"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1243"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199801000-00004"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.908"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2051"},{"key":"e_1_2_6_27_1","unstructured":"New Mexico Department of Health Indicator\u2010Based Information System for Public Health. Standardized mortality ratio.https:\/\/ibis.health.state.nm.us\/resource\/SMR_ISR.html. Accessed March 24 2020."},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.7399"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gly283"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.2563"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000837"},{"key":"e_1_2_6_32_1","volume-title":"Psychotropic Drug Safety Initiative: Phase 2 Evaluation of Impact. VA Office of Mental Health Operations","author":"Wiechers IR","year":"2017"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1573777"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMhpr1804089"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006544"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2893"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.16825","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgs.16825","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.16825","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:40:46Z","timestamp":1762170046000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.16825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1111\/jgs.16825"],"URL":"https:\/\/doi.org\/10.1111\/jgs.16825","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,20]]},"assertion":[{"value":"2020-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}